Neurovascular Complications of Ovarian Hyperstimulation Syndrome (OHSS): From Pathophysiology to Recent Treatment Options

被引:9
作者
Calabro, Rocco S. [1 ]
Gervasi, Giuseppe [2 ]
Leo, Antonino [1 ]
De Luca, Rosaria [1 ]
Balletta, Tina [1 ]
Casella, Carmela [2 ]
Triolo, Onofrio [3 ]
Bramanti, Placido [1 ]
机构
[1] IRCCS Ctr Neurolesi Bonino Pulejo, Messina, Italy
[2] Univ Messina, Dept Neurosci, Messina, Italy
[3] Univ Messina, Dept Obstet Gynecol & Reprod Med, Messina, Italy
关键词
Arterial ischemia assisted reproductive technology; follicle stimulation hormone; iatrogenic complications; mortality risk; neurovascular complications; ovarian hyperstimulation syndrome;
D O I
10.2174/1872214808666140606142820
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Ovarian hyperstimulation syndrome (OHSS) is a severe iatrogenic complication of ovulation induction, which has a very serious impact on the patient's health, as it is often associated with a high morbidity and mortality risk. Indeed, patients classified as having severe OHSS presented with liquid imbalance signs (such as rapid weight gain, tense ascites, respiratory difficulty and progressive oliguria), which are related to the fluid shift from the intravascular space to third space compartments subsequent to an increased capillary permeability. In this way, cardiovascular system findings include decreased intravascular volume, decreased blood pressure, decreased central venous perfusion, and compensatory increased heart rate and cardiac output with arterial vasodilation might be found concomitantly. Notwithstanding that venous thromboembolic phenomena are a possible complication in advanced phases of OHSS, arterial ischemia involving the cerebral circulation is a rare but recently reported problem. The pathogenesis of thromboembolism in OHSS is not fully understood, even though hemoconcentration and blood hyperviscosity seem to play a role in developing thrombotic changes into both venous and arterial system. Interestingly, the presence of cardiac abnormalities in combination with inherited or acquired hypercoagulable state seems to increase the risk of cerebral infarct in these subjects, as recently shown by our group. This review is aimed at investigating the pathomechanism and the management of neurovascular complications related to OHSS, including new treatment options.
引用
收藏
页码:109 / 116
页数:8
相关论文
共 53 条
[11]   Intravenous albumin does not prevent moderate-severe ovarian hyperstimulation syndrome in high-risk IVF patients:: a randomized controlled study [J].
Bellver, J ;
Muñoz, EA ;
Ballesteros, A ;
Soares, SR ;
Bosch, E ;
Simón, C ;
Pellicer, A ;
Remohí, J .
HUMAN REPRODUCTION, 2003, 18 (11) :2283-2288
[12]  
Bevec D., 2009, Use of melanin concentrating hormone and met-enkephalin as therapeutic agents, Patent No. [WO2009033735, 2009033735]
[13]   Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study [J].
Bodri, Daniel ;
Guillen, Juan Jose ;
Galindo, Anna ;
Mataro, Daniel ;
Pujol, Aida ;
Coll, Oriol .
FERTILITY AND STERILITY, 2009, 91 (02) :365-371
[14]   Can interaction between atrial septal abnormalities and genetic prothrombotic polymorphisms play a role in cryptogenic ischemic stroke? Description of a family [J].
Calabro, Rocco Salvatore ;
Gervasi, Giuseppe ;
Bramanti, Placido .
NEUROLOGICAL SCIENCES, 2012, 33 (01) :117-119
[15]   Update on management of ovarian hyperstimulation syndrome [J].
Chen, Chin-Der ;
Wu, Mng Ying ;
Chao, Kuang-Han ;
Lien, Yih-Ron ;
Chen, Shee-Uan ;
Yang, Yu-Shih .
TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2011, 50 (01) :2-10
[16]   Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review [J].
Delvigne, A ;
Rozenberg, S .
HUMAN REPRODUCTION UPDATE, 2002, 8 (06) :559-577
[17]   Review of clinical course and treatment of ovarian hyperstimulation syndrome (OHSS) [J].
Delvigne, A ;
Rozenberg, S .
HUMAN REPRODUCTION UPDATE, 2003, 9 (01) :77-96
[18]   Aphasia: an early uncommon complication of ovarian stimulation without ovarian hyperstimulation syndrome [J].
Demirol, Aygul ;
Guven, Suleyman ;
Gurgan, Timur .
REPRODUCTIVE BIOMEDICINE ONLINE, 2007, 14 (01) :29-31
[19]   Increased prevalence of thrombophilia among women with severe ovarian hyperstimulation syndrome [J].
Dulitzky, M ;
Cohen, SB ;
Inbal, A ;
Seidman, DS ;
Soriano, D ;
Lidor, A ;
Mashiach, S ;
Rabinovici, J .
FERTILITY AND STERILITY, 2002, 77 (03) :463-467
[20]   The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study [J].
Engmann, Lawrence ;
DiLuigi, Andrea ;
Schmidt, David ;
Nulsen, John ;
Maier, Donald ;
Benadiva, Claudio .
FERTILITY AND STERILITY, 2008, 89 (01) :84-91